KUALA LUMPUR: IHH Healthcare Bhd today says it has made virtual consultation available across all its key markets including Malaysia, Singapore, Turkey, India and Hong Kong.
IHH said the expansion was an integral part of its refreshed strategy to innovate to meet evolving patient needs, and was timely amid the Covid-19 pandemic.
"The integration of telemedicine with existing healthcare services ranging from primary to quaternary care allows patients to receive quality medical care in the comfort and security of their own homes.
"They are now able to enjoy more convenient access to IHH's full suite of services from consultation to doorstep drug delivery, with the option for a seamless transfer to the group's brick-and-mortar facilities, if necessary," IHH managing director and chief executive officer Dr Kelvin Loh said.
IHH said the rollout of telemedicine was spearheaded at the country level to cater to the varying needs of each market.
The group said it had seen strong traction for its virtual consultation services.
"For example, Fortis has conducted more than 12,600 teleconsultations since it launched the service across 23 of its hospitals in India on March 27 and sees an average of more than 370 patients online daily."
In Turkey, more than 1,300 teleconsultations have been conducted at Acibadem hospitals since its Doctor Online platform went live on March 31 this year.
Earlier this March, IHH invested into regional telehealth platform Doctor Anywhere as a response to shifting patient trends.
It had also invested in Lucence Diagnostics that offers blood-based screening and treatment monitoring solutions for oncology patients.